Showing 3631-3640 of 5773 results for "".
- KYS Vision Reports Clinical Trial Results of Its Remote Physiologic Monitoring System for Patients With Chronic Retinal Conditionshttps://modernod.com/news/kys-vision-reports-clinical-trial-results-of-its-remote-physiologic-monitoring-system-for-patients-with-chronic-retinal-conditions/2481207/KYS Vision announced clinical trial results of its Macustat macular function scan for the remote monitoring of central retinal function. The study was published in the peer-reviewed journal Digital Health1 in October 2022. The study is one
- Aurion Biotech Wins Prix Galien Startup Awardhttps://modernod.com/news/aurion-biotech-wins-prix-galien-startup-award/2481203/Aurion Biotech announced it has won the Prix Galien Award for "Best Startup in Biotech/Pharma." “The Prix Galien is known throughout the world for its ability to shine a bright light on the most important, impactful innovations in medicine, biotechnology, healthcare
- Altris Launches New Artificial Intelligence Platform for Automated OCT Scanshttps://modernod.com/news/altris-launches-new-artificial-intelligence-platform-for-automated-oct-scans/2481202/Altris Inc. announced the launch of Altris AI, an artificial-intelligence-powered software platform designed to automate OCT examination. The secure, cloud-based platform provides fast analysis and visualization of 100 pathologies and pathological signs, including rare ones, according to Altris.<
- Lumata Health Raises $4 Million in Series A Funding to Scale its Human-Led, Intelligent Eye Care Management Platformhttps://modernod.com/news/lumata-health-raises-4-million-in-series-a-funding-to-scale-its-human-led-intelligent-eye-care-management-platform/2481201/Lumata Health announces $4 million in new venture funding to scale its impact throughout the United States. Lumata Health currently serves thousands of patients suffering from vision-threatening chronic eye conditions through partnerships with ophthalmology clinics and h
- Genentech: Topline Phase 3 Results Show Vabysmo Improved Vision in People With RVOhttps://modernod.com/news/genentech-topline-phase-3-results-show-vabysmo-improved-vision-in-people-with-rvo/2481199/Genentech announced positive topline results from two global phase 3 studies, BALATON and COMINO, evaluating the first and only bispecific antibody for the eye, Vabysmo (faricimab-svoa), in macular edema due to branch and central retinal vein occlusion (BRVO and CRVO).
- Amydis Awarded Third Grant From The Michael J. Fox Foundation To Support First-In-Human Study of a Retinal Tracer for Parkinson’s Diseasehttps://modernod.com/news/amydis-awarded-third-grant-from-the-michael-j-fox-foundation-to-support-first-in-human-study-of-a-retinal-tracer-for-parkinsons-disease/2481198/Amydis announced it has been awarded a third grant for $1.5 million from The Michael J. Fox Foundation for Parkinson's Research (MJFF). This grant will support the first-in-human study of a retinal tracer targeting alpha-synuclein (ASYN) in a Prospective Randomized Open, B
- Alcon to Celebrate 75 Years and Showcase Contact Lens Innovations at #Academy22https://modernod.com/news/alcon-to-celebrate-75-years-and-showcase-contact-lens-innovations-at-academy22/2481197/Alcon will feature a host of innovations across its portfolio of products along with pertinent practice takeaways at the American Academy of Optometry Annual Meeting (#Academy22) in San Diego, California, on October 27, 2022. The meeting coincides with Alcon’s Diamond Jubilee, celebrating 7
- Johnson & Johnson Vision Reveals New Data on Blue-Violet Light Filtering Technology in Acuvue Oasys Max 1-Day Contact Lenseshttps://modernod.com/news/johnson-johnson-vision-reveals-new-data-on-blue-violet-light-filtering-technology-in-acuvue-oasys-max-1-day-contact-lenses/2481196/Johnson & Johnson Vision Care will present new data on the positive effects of wearing blue-violet light filtering contact lenses at the 2022 American Academy of Optometry (AAO) annual meeting in San Diego, October 26-29. "As a result of our increasingly digital
- Radiance Therapeutics Co-Founders Wendell Lutz, PhD, Honored by the American Society of Radiation Oncology (ASTRO)https://modernod.com/news/radiance-therapeutics-co-founders-wendell-lutz-phd-honored-by-the-american-society-of-radiation-oncology-astro/2481194/Radiance Therapeutics announced that one of its co-founders, Wendell Lutz, PhD, was honored by the American Society of Radiation Oncology (ASTRO) during the Annual Meeting Awards Ceremony in San Antonio on October 25, 2022. According to Radiance, in 1986, Dr. Lutz revolutionized t
- DORC Acquires Peregrine Surgical and Completes Acquisition of the Remaining Stake in WEFIShttps://modernod.com/news/dorc-acquires-peregrine-surgical-and-completes-acquisition-of-the-remaining-stake-in-wefis/2481192/DORC announced the acquisition of Peregrine Surgical and the acquisition of the full ownership of WEFIS GmbH following an initial equity investment announced earlier in 2022. Financial terms of the deals were not disclosed. DORC says both acquisitions extend the productio